To Investors

This FAQ represents a set of Questions and Answers that were included in the most recent Landec Quarter Earnings Release (Read Press Release issued on March 31, 2020 for the quarter ended February 23, 2020) and offers comments for understanding Landec's business. Following the Disclaimer below, there is a list of questions. Thank you for your interest in Landec.

Important Cautions Regarding Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this news release are forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially, including such factors among others, as the timing and expenses associated with operations, the ability to achieve acceptance of the Company's new products in the market place, weather conditions that can affect the supply and price of produce, the timing of regulatory approvals, the ability to successfully integrate Yucatan Foods into the Landec Curation Foods business, and the mix between domestic and international sales. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to our filings with the Securities and Exchange Commission (“SEC”), including the risk factors contained in our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K. Forward-looking statements represent management’s current expectations and are inherently uncertain. Except as required by law, we do not undertake any obligation to update forward-looking statements made by us to reflect subsequent events or circumstances.

When did the Company complete its corporate transition to Lifecore Biomedical, Inc. (from Landec Corp.)?
The Company completed its corporate name change and ticker change on November [X], 2022. This was the result of a strategic decision to monetize its Curation Foods assets and focus its resources on its rapidly growing, profitable Lifecore Biomedical business.
How can I find out about my Lifecore Biomedical stock?
If you are a registered shareholder, please contact the transfer agent, Broadridge Corporate Issuer Solutions, Inc. at 877-830-4932. If you hold your shares in a brokerage account, you will need to contact your financial advisor for more information.
What Is a transfer agent?
A transfer agent is a professional agency employed by a corporation to handle the transfer of certificates, conversion of securities, mailings to stockholders, payments of dividends, stock subscriptions, and maintaining the books of the corporation. Broadridge Corporate Issuer Solutions, Inc. is the transfer agent for Lifecore Biomedical, Inc.
What does it mean to be a registered shareholder?
You are a registered shareholder if your name appears on the certificate or in the registration of the security and in the corporation books.
What does it mean to be a beneficial shareholder?
You are a beneficial shareholder if your shares are held through a brokerage account, as opposed to registered directly in your name. This is also referred to as holding shares in "street name".
What are book entry shares?
Book entry form of registered ownership allows a person to own shares without having physical stock certificates in their possession.
Independent Public Accountants
Ernst & Young LLP
How can I get more information about the performance of the stock?
To get more information about stock performance, go to the Financials and Stock Information area of our site, which includes stock performance charts, SEC filings and our annual reports.
When is your next earnings call?
For a listing of quarterly earnings call dates, please, visit the Events & Presentations page on our sites.